Table 1.
Demographic and Clinical Data of the Two Study Groups.
| Variable | ESRD patients | Healthy controls | p-value |
|---|---|---|---|
| (n = 32) | (n = 45) | ||
| Age (years) | 44.4 ± 15.0 | 38.7 ± 13.1 | 0.080b |
| Sex (male/female) | 17/15 | 23/22 | 0.862a |
| Education (years) | 12.3 ± 2.7 | 12.9 ± 3.4 | 0.404b |
| Dialysis duration (month) | 12.3 ± 12.2 | – | – |
| creatinine (μmol/L) | 642.3 ± 332.6 | – | – |
| Urea (mmol/L) | 22.0 ± 9.0 | – | – |
| Ca2+ (mmol/L) | 2.1 ± 0.3 | – | – |
| K+ (mmol/L) | 4.5 ± 0.8 | – | – |
| Na+ (mmo/L) | 139.3 ± 3.2 | – | – |
| Hemoglobin (g/L) | 92.7 ± 18.9 | – | – |
| Hematocrit | 29.2 ± 6.0 | – | – |
| Cholesterol (mmol/L) | 4.8 ± 2.2 | – | – |
Values are represented as the mean ± SD.
ESRD, end-stage renal disease.
a
The p-value was obtained by Chi-square test.
b
The p-value was obtained by two-sided two-sample t-test.